Response to mold contamination of intravenous magnesium sulfate produced by a compounding pharmacy

JAMA Intern Med. 2014 Apr;174(4):630-1. doi: 10.1001/jamainternmed.2013.13772.
No abstract available

MeSH terms

  • Centers for Disease Control and Prevention, U.S.
  • Drug Compounding
  • Drug Contamination*
  • Fungi / isolation & purification*
  • Humans
  • Infection Control / methods
  • Magnesium Sulfate / administration & dosage*
  • Mycoses / prevention & control
  • Population Surveillance
  • United States
  • United States Food and Drug Administration

Substances

  • Magnesium Sulfate